hae_ʻaoʻao

huahana

Mea hana lepo Fasoracetam CAS No.: 110958-19-5 99% maʻemaʻe min. no nā mea hoʻohui

Wehewehe Pōkole:

ʻO ka Fasoracetam kemika he lāʻau lapaʻau i hana ʻia no kahi papa lāʻau i kapa ʻia ʻo ka papa dihydropyridine pyrrolidone.


Nā kikoʻī huahana

Nā Lepili Huahana

Wikiō Huahana

Nā Palena Huahana

Inoa huahana

ʻO ka Fasoracetam

Inoa ʻē aʻe

FASORACETAM;

(5R)-5-(piperidine-1-carbonyl)-2-pyrrolidone;

(5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one;

(5R)-5-piperidin-1-ylcarbonylpyrrolidin-2-one

Helu CAS.

110958-19-5

ʻO ke ʻano molekole

C10H16N2O2

Kaumaha molekole

196.25

Maʻemaʻe

99.0%

helehelena

Pauka aniani keʻokeʻo

Hoʻopili ʻana

1 kg/ʻeke 25kg/pahu

Noi

Nootropic

Hoʻolauna huahana

ʻO Fasoracetam, kahi hui nootropic i hoʻomohala mua ʻia ma Iapana. Kaʻana like ia i nā ʻano like me nā racemates ʻē aʻe e like me piracetam, akā hōʻike i nā ʻano hana kūikawā. Manaʻo ʻia ʻo Fasoracetam e hoʻololi i nā hopena o nā neurotransmitters like ʻole i loko o ka lolo, me GABA, glutamatergic, a me nā ʻōnaehana cholinergic. Ma ka hoʻopili ʻana i ka hoʻokuʻu ʻana a me ka lawe ʻana o kēia mau neurotransmitters, hiki i ka fasoracetam ke hoʻomaikaʻi i nā hana cognitive e like me ka nānā ʻana, ka hoʻopaʻa ʻana i ka hoʻomanaʻo, a me ka hana ʻana i ka ʻike. Hōʻike ka noiʻi a me nā hōʻike anecdotal e hiki i ka fasoracetam ke hāʻawi i nā pono cognitive he nui. ʻO kekahi o kāna mau hopena nui, ʻo ia ka hoʻonui ʻana i ka noʻonoʻo a me ka nānā ʻana, e lilo ia i mea kōkua no ka poʻe e ʻeha nei i ka maʻi hemahema o ka nānā ʻana a i ʻole ka maʻi hyperactivity hemahema (ADD/ADHD). Ua hōʻike nā haʻawina mua i nā hopena hoʻohiki, e hōʻike ana i ka hiki o ka fasoracetam ke hoʻomaikaʻi i ka nānā ʻana, hoʻemi i ka impulsivity a hoʻonui i ka mana cognitive. Eia kekahi, hōʻike nā haʻawina holoholona e hoʻonui ʻo Fasoracetam i ka potentiation lōʻihi, kahi hana e pili ana i ka hoʻokumu ʻana i ka hoʻomanaʻo a me ka plasticity synaptic.

Hiʻona

(1) Maʻemaʻe kiʻekiʻe: Hiki iā Fasoracetam ke loaʻa nā huahana maʻemaʻe kiʻekiʻe ma o nā kaʻina hana hoʻomaʻemaʻe. ʻO ke ʻano o ka maʻemaʻe kiʻekiʻe ʻoi aku ka maikaʻi o ka bioavailability a me nā hopena ʻino liʻiliʻi.

(2) Palekana: Ua hōʻike nā haʻawina ua ʻae maikaʻi ʻia ka fasoracetam a ʻaʻole hōʻike i nā hopena koʻikoʻi ke hoʻohana ʻia i loko o nā lāʻau i ʻōlelo ʻia.

(3) Paʻa: He kūpaʻa maikaʻi ko Fasoracetam a hiki ke mālama i kāna hana a me kona hopena ma lalo o nā ʻano like ʻole a me nā kūlana mālama.

Nā noi

Ua kū mai ʻo Fasoracetam ma ke ʻano he hui hoihoi me ka hiki ke hoʻonui i nā mākau noʻonoʻo, ʻoiai ka hoʻomanaʻo, ka nānā ʻana, a me ke aʻo ʻana, a hiki ke hoʻohana ʻia ma ke ʻano he mea hoʻohui meaʻai. Hana kēia huahana ma ke ʻano he mea hoʻonui hoʻomanaʻo ma ka hoʻoulu ʻana i nā mea loaʻa glutamate metabolic. Ma ke kahua olaola, hoʻohana ʻia ʻo Fasoracetam ma ke ʻano he mea hoʻopaʻa koho e aʻo i nā kaʻina hana olaola e like me ka hōʻailona cell a me ka apoptosis.


  • Ma mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou